rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Aptevo Therapeutics Inc.

APVO · Nasdaq

Health CareBiotechnologyNot moving yet

APVO stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 57.6% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
18% -12 in 4 wk
Insider buys, 12 months
$20K
Insider sales, 12 months
$0
Officials’ trades on record
1
Institutions holding
8 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

22 Apr – 21 Oct
16%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$19KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Steve Cohen House: U.S. House ClerkTN09sold$0k24 Jun 2019filed 3 Jul 2019

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders8+0 on the quarter
New · exited1 · 1
Reported value$128K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 202612,713$56K00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202610,821$48K-2,516−18.9%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 20264,142$18K00.0%
UBS Group AGreduced · filed 13 Aug 2026730$3,242-2,715−78.8%
OSAIC HOLDINGS, INC.unchanged · filed 14 Aug 2026360$1,59600.0%
SBI Securities Co., Ltd.unchanged · filed 23 Jul 2026109$48400.0%
BARCLAYS PLCnew · filed 14 Aug 202631$138+31
DANSKE BANK A/Sunchanged · filed 10 Aug 20261$400.0%
31 Mar 2024 – 30 Jun 2026
71216Mar 24Sep 24Jun 25Dec 25Jun 26

Everyone who traded it

Barbara Lopez Kunz Company insiderDirector · last 6 Aug 20261 · 0
Daniel Abdun-Nabi Company insiderDirector · last 6 Aug 20261 · 0
Daphne Taylor Company insiderSVP, CFO · last 6 Aug 20260 · 0
Dirk Huebner Company insiderSVP, CMO · last 6 Aug 20260 · 0
Grady Grant III Company insiderDirector · last 6 Aug 20262 · 0
Jeffrey G. Lamothe Company insiderPresident and CEO · last 6 Aug 20260 · 0
John Niederhuber Company insiderDirector · last 6 Aug 20261 · 0
Marvin L. White Company insiderExecutive Chair · last 6 Aug 20265 · 1
SoYoung Kwon Company insiderSVP, GC, BD & Corp Affairs · last 6 Aug 20260 · 0
Zsolt Harsanyi Company insiderDirector · last 6 Aug 20261 · 0
Fuad El-Hibri Company insiderDirector · last 3 Dec 202110 · 0
Tang Capital Partners Lp Company insiderOther · last 23 Nov 20213 · 4

Same industry

MRNA ModernaLeading+168%
ENTX Entera BioLeading+53%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-124%
Share count trendFY 2025 · to 26 Mar 202618.4%
Cash and equivalentsFY 2025 · to 31 Dec 2025$21.6M

Analyst forecasts

No analyst forecasts yet.